PTCH1 and nevoid basal cell carcinoma syndrome: Therefore, it is reasonably assumed that the mutation analysis of genes other than PTCH1 using WES may define potential diagnostic, preventive, and therapeutic opportunities for Gorlin syndrome and illuminate disease mechanisms.